{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:09:48Z","timestamp":1791684588905,"version":"4.3.4"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1007\/s00296-010-1692-y","type":"journal-article","created":{"date-parts":[[2010,12,3]],"date-time":"2010-12-03T11:24:55Z","timestamp":1291375495000},"page":"639-643","source":"Crossref","is-referenced-by-count":26,"title":["Serum concentration of interleukin 15, interleukin 2 receptor and TNF receptor in patients with polymyositis and dermatomyositis: correlation to disease activity"],"prefix":"10.1007","volume":"32","author":[{"given":"Pawel","family":"Mielnik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Chwalinska-Sadowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Wiesik-Szewczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wlodzimierz","family":"Maslinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzena","family":"Olesinska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,12,4]]},"reference":[{"key":"1692_CR1","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1182\/blood.V97.1.14","volume":"97","author":"TA Fehniger","year":"2001","unstructured":"Fehniger TA, Caligiuri MA (2001) Interleukin 15: biology and relevance to human disease. Blood 97:14\u201332","journal-title":"Blood"},{"key":"1692_CR2","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1093\/intimm\/dxf062","volume":"14","author":"T Sugiura","year":"2002","unstructured":"Sugiura T, Harigai M, Kawaguchi Y, Takagi K, Fukasawa C, Ohsako-Higami S et al (2002) N.Increased IL-15 production of muscle cells in polymyositis and dermatomyositis. Int Immunol 14:917\u2013924","journal-title":"Int Immunol"},{"key":"1692_CR3","first-page":"2389","volume":"28","author":"J Suzuki","year":"2001","unstructured":"Suzuki J, Morimoto S, Amano H, Tokano Y, Takasaki Y, Hashimoto H (2001) Serum levels of interleukin 15 in patients with rheumatic diseases. J Rheumatol 28:2389\u20132391","journal-title":"J Rheumatol"},{"key":"1692_CR4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s002960050111","volume":"19","author":"O Elkayam","year":"2000","unstructured":"Elkayam O, Yaron I, Shirazi I, Yaron M, Caspi D (2000) Serum levels of IL-10, IL-6, IL-1ra, and sIL-2R in patients with psoriatic arthritis. Rheumatol Int 19:101\u2013105","journal-title":"Rheumatol Int"},{"key":"1692_CR5","first-page":"321","volume":"43","author":"L Chrobak","year":"1996","unstructured":"Chrobak L, Podzimek K, Pliskova L, Kerekes Z, Zak P, Voglova J et al (1996) Serum soluble IL-2 receptor as a reliable and noninvasive marker of disease activity in patients with hairy cell leukemia. Neoplasma 43:321\u2013325","journal-title":"Neoplasma"},{"key":"1692_CR6","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/rheumatology\/36.6.656","volume":"36","author":"MY Samsonov","year":"1997","unstructured":"Samsonov MY, Nassonov EL, Tilz GP, Geht BM, Demel U, Gurkina GT et al (1997) Elevated serum levels of neopterin in adult patients with polymyositis\/dermatomyositis. Br J Rheumatol 36:656\u2013660","journal-title":"Br J Rheumatol"},{"key":"1692_CR7","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292:344\u2013347","journal-title":"N Engl J Med"},{"key":"1692_CR8","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.4049\/jimmunol.169.4.1760","volume":"169","author":"M Kurowska","year":"2002","unstructured":"Kurowska M, Rudnicka W, Kontny E, Janicka I, Chorazy M, Kowalczewski J et al (2002) Fibroblast-like synoviocytes from rheumatoid arthritis patients express functional IL-15 receptor complex: endogenous IL-15 in autocrine fashion enhances cell proliferation and expression of Bcl-x(L) and Bcl-2. J Immunol 169:1760\u20131767","journal-title":"J Immunol"},{"issue":"S2","key":"1692_CR9","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1136\/ard.61.suppl_2.ii100","volume":"61","author":"FY Liew","year":"2002","unstructured":"Liew FY, McInnes IB (2002) Role of interleukin 15 and interleukin 18 in inflammatory response. Ann Rheum Dis 61(S2):100\u2013102","journal-title":"Ann Rheum Dis"},{"key":"1692_CR10","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1002\/art.21249","volume":"52","author":"B Baslund","year":"2005","unstructured":"Baslund B, Tvede N, Danneskiold-Samsoe B, Larsson P, Panayi G, Petersen J et al (2005) Targeting interleukin-15 in patients with rheumatoid arthritis: a proof-of-concept study. Arthritis Rheum 52:2686\u20132692","journal-title":"Arthritis Rheum"},{"key":"1692_CR11","first-page":"422","volume":"50","author":"P Horak","year":"2004","unstructured":"Horak P, Hermanova Z, Ordeltova M, Faltynek L, Kusa L, Budikova M et al (2004) Neopterin and a soluble interleukin-2 receptor in patients with systemic lupus erythematodes. Vnitr Lek 50:422\u2013427","journal-title":"Vnitr Lek"},{"key":"1692_CR12","first-page":"71","volume":"12","author":"A Franczuk","year":"2004","unstructured":"Franczuk A, Szepietowski JC, Noworolska A (2004) Serum concentrations of interleukin-2 soluble receptor (IL-2 sR) in patients with vitiligo: relationship with type and extent of the disease. Acta Dermatovenerol Croat 12:71\u201376","journal-title":"Acta Dermatovenerol Croat"},{"key":"1692_CR13","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1093\/rheumatology\/40.12.1398","volume":"40","author":"T Fujii","year":"2001","unstructured":"Fujii T, Nojima T, Yasuoka H, Satoh S, Nakamura K, Kuwana M et al (2001) Cytokine and immunogenetic profiles in Japanese patients with adult Still\u2019s disease. Association with chronic articular disease. Rheumatology (Oxford) 40:1398\u20131404","journal-title":"Rheumatology (Oxford)"},{"key":"1692_CR14","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s100670070027","volume":"19","author":"T Shimizu","year":"2000","unstructured":"Shimizu T, Tomita Y, Son K, Nishinarita S, Sawada S, Horie T (2000) Elevation of serum soluble tumour necrosis factor receptors in patients with polymyositis and dermatomyositis. Clin Rheumatol 19:352\u2013359","journal-title":"Clin Rheumatol"},{"key":"1692_CR15","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1600-0609.2006.00702.x","volume":"77","author":"N Goto","year":"2006","unstructured":"Goto N, Tsurumi H, Takemura M, Hara T, Sawada M, Kasahara S et al (2006) Serum-soluble tumor necrosis factor receptor 2 (sTNF-R2) level determines clinical outcome in patients with aggressive non-Hodgkin\u2019s lymphoma. Eur J Haematol 77:217\u2013225","journal-title":"Eur J Haematol"},{"key":"1692_CR16","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/0959-8049(95)00541-2","volume":"32A","author":"J Viac","year":"1996","unstructured":"Viac J, Vincent C, Palacio S, Schmitt D, Claudy A (1996) Tumour necrosis factor (TNF) soluble receptors in malignant melanoma: correlation with soluble ICAM-1 levels. Eur J Cancer 32A:447\u2013449","journal-title":"Eur J Cancer"},{"key":"1692_CR17","first-page":"3057","volume":"23","author":"G Holzer","year":"2003","unstructured":"Holzer G, Pfandlsteiner T, Blahovec H, Trieb K, Kotz R (2003) Serum levels of TNF-beta and sTNF-R in patients with malignant bone tumors. Anticancer Res 23:3057\u20133059","journal-title":"Anticancer Res"},{"key":"1692_CR18","first-page":"661","volume":"6","author":"P Tesarova","year":"2000","unstructured":"Tesarova P, Kvasnicka J, Umlaufova A, Homolkova H, Jirsa M, Tesar V (2000) Soluble TNF and IL-2 receptors in patients with breast cancer. Med Sci Monit 6:661\u2013667","journal-title":"Med Sci Monit"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s00296-010-1692-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,19]],"date-time":"2017-06-19T16:49:28Z","timestamp":1497890968000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-010-1692-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,4]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["1692"],"URL":"https:\/\/doi.org\/10.1007\/s00296-010-1692-y","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,4]]}}}